Arizona Originals Podcast featuring Jordan Lancaster

This week our guest is Jordan Lancaster - the co-founder and Chief Scientific Officer of Avery Therapeutics, a Tucson-based company working to solve the problem of heart tissue regeneration. Jordan comes from a long line of cardiologists and finds himself focused on the research side of the heart…and now is leading an entrepreneurial endeavor to bring scientific innovations to make the next leap forward in cardiac care.

Read More
Avery Therapeutics, Inc. to present at the Biotech Showcase™ Annual Conference on January 8, 2018.

Avery Therapeutics, Inc., today announced that it will present at Biotech Showcase™ 2018, to be help January 8-10 during the most important week in healthcare at the Hilton San Francisco Union Square.

Read More
Avery Therapeutics to be honored with an AZBio Fast Lane Award

Arizona life science and business leaders as well as guests from across the country will be on hand to applaud the Avery Therapeutics team for their progress in developing a novel lifesaving medical device to address heart failure.

Read More
Tucson Tech: University of Arizona startup advances living heart patch

Repairing beating human hearts with living patches is the aim of Avery Therapeutics, a startup company founded on technology developed by University of Arizona researchers.

Read More
University of Arizona Startups Draw Silicon Valley Attention to Tucson

The University of Arizona's Tech Launch Arizona invited Avery Therapeutics as one of three showcase technologies to Silicon Valley. The road show took place at TechCode, an accelerator located in Mountain View, CA and provided a unique experience to pitch in front of investors from around the world.

Read More
Avery Therapeutics: Developing a heart graft that pulses on its own

Avery Therapeutics was highlighted in a special “Hotbed of Innovation” section of the Summer 2017 issue of Biz Tucson – a Tucson centric business publication - (pg 82)

Read More
Startup Commercializes Beating Heart Graft Invented at University of Arizona

Avery Therapeutics, Inc., has licensed a beating heart graft technology invented at the University of Arizona College of Medicine-Tucson. Pre-clinical studies have already shown that the technology, called MyCardia™, improves heart function.

Read More
Jordan Lancaster, MyCardia™ Co-Inventor, Discusses the use of iPSCs

Award from Cellular Dynamics International to explore the use of iPSC-derived cardiomyocytes in engineered tissue results in beating heart graft.

Read More
Shout Out for Avery Therapeutics at US House Meeting on Small Business

At ~33 minutes Representative Ron Barber showcases University of Arizona support programs for small businesses including Avery Therapeutics, a local innovative business commercializing a new technology for heart failure.

Read More
University of Arizona Awards Asset Development Funding for MyCardia™ Technology

Joann MacMaster, TLA’s director of business development, “these asset development projects can significantly enhance a technology’s viability and readiness for the market, thereby increasing its attractiveness to investors and entrepreneurs interested in building startups around these UA technologies.

Read More